A Case of @entity8523 Treated with @entity3003 and XXXX plus Bevacizumab.

@entity1 @entity3003 @entity2 @entity1311 @entity8523 @entity3
Background. @entity8523 is a rare @entity2 similar to fetal lung tissues. Surgical resection at early stage is more curative than other treatments, but there is no standard treatment in unresectable cases. We show a case treated with @entity3003 and @entity1311 plus bevacizumab. Case. A 68-year-old @entity1 received surgical resection and was diagnosed with @entity8523 (pT3N0M0 stage IIB). @entity3 to the spleen was detected six weeks after the surgery. @entity3003 , @entity1311 , and bevacizumab were administered and showed an effect on the @entity3 . Four courses of the chemotherapy were completed, but a @entity3 was found and the @entity3 in the spleen was enlarged. After that, chemotherapy was not effective afterward and he died of the progression of @entity8523 on the 292nd day of illness. Conclusion. In this case, chemotherapy with @entity3003 and @entity1311 plus bevacizumab was temporarily efficacious for @entity8523 .
